STSelçuk Teke

Selçuk Teke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Selçuk Teke has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Response to comment “Bone mineral density in pediatric celiac disease: Clinical, biochemical, and serologic profiles—a retrospective cohort study”

    by Selcuk Teke

    We thank the authors for their interest in our study and for their constructive comments. We appreciate their emphasis on the need to update pediatric bone mineral density (BMD) reference data in Türkiye and on the potential future role of artificial intelligence (AI)-assisted approaches in pediatric bone health assessment. In our study, lumbar BMD was assessed at the L2–L4 vertebrae, and age-adjusted BMD z-scores (BMD-AAz) and height-adjusted BMD z-scores (BMD-HAz) were calculated using reference curves derived from healthy Turkish children (1,2). Although evaluating whether these reference curves require updating was beyond the scope of our study, we consider the authors’ emphasis on the need for updated and more representative national reference data important. We agree that pediatric reference data derived from larger, multicenter, and contemporary populations could contribute to the interpretation of dual-energy X-ray absorptiometry (DEXA) findings and improve comparability across future studies in Türkiye. We also appreciate the authors’ comments regarding our findings in the gluten-free diet (GFD)-adherent follow-up group (FU-Adh group). Although higher BMD values were observed in this group, our study compared patients assessed at diagnosis with those assessed during follow-up rather than evaluating serial DEXA measurements in the same individuals. Therefore, prospective studies incorporating repeated DEXA measurements may further clarify changes in bone mineralization during follow-up on a GFD. Finally, we agree that AI-assisted methods represent a promising area in pediatric bone health assessment. Their ability to integrate imaging, clinical, and demographic data may improve risk stratification; however, prospective validation in pediatric populations will be important before their broader clinical implementation. We thank the authors once again for their valuable comments and for highlighting important directions for future research.

  • Infliximab-Associated Paradoxical Psoriasiform Reaction in Pediatric Ulcerative Colitis: Resolution with Ustekinumab

    by Birce İ. Akçay, Yasin M. Ergen, Selçuk Teke, Ercan Çetin, Zeynep Büşra Balık, Ayça Ataş, Necati Balamtekin

    Was not provided for this article.

  • Carbamazepine-Associated Granulomatous Hepatitis in a Pediatric Patient: A Case Report

    by Selcuk Teke, Yasin M. Ergen, Birce I. Akcay, Tugba Cavis, Edibe G. Basaran, Bulent Unay, Necati Balamtekin

    Was not provided for this article.

  • Associations Between Weight Status, Peer Victimization, and Mental Health in Clinically Referred Children: A Cross-Sectional Study

    by Halenur Teke, Mehri Durak, Selcuk Teke, Burcin Ozlem Ates, Seda Bozduman Celebi, Mehmet Ayhan Congologlu, Necati Balamtekin

  • The illusion of competence: Evaluating the clinical reasoning of large language models in pediatric gastroenterology

    by Yasin Maruf Ergen, Selçuk Teke, Edibe Gözde Başaran, Necati Balamtekin

    Objective: To evaluate the diagnostic accuracy and clinical reasoning of three frontier large language models (LLMs) across standardized pediatric gastroenterology, hepatology, and nutrition (PGHN) clinical vignettes. Methods: In this cross‐sectional study, 25 fictional PGHN vignettes were developed by one board‐certified pediatric gastroenterologist and evaluated using three LLMs: Gemini 3.1 Pro, ChatGPT 5.4 Thinking, and Claude Sonnet 4.6 Extended. A conditional two‐step prompting protocol was applied. Three blinded, PGHN‐certified co‐authors independently scored responses using a structured instrument covering four domains (diagnostic accuracy, management, patient safety, reference quality; 0–2 each) and a global quality of clinical reasoning (QCR) score (1–5 Likert scale). Interobserver reliability was assessed using the intraclass correlation coefficient (ICC). Group differences were analyzed using the Kruskal–Wallis H test with Dunn post‐hoc correction. Results: Interobserver reliability was excellent (ICC: 0.98 for domains; 0.87 for QCR). All three models achieved perfect diagnostic accuracy (median 2.00, interquartile range: 2.00–2.00). Statistically significant intermodel differences were identified in reference quality ( p = 0.048) and QCR ( p = 0.049). Claude achieved significantly higher QCR scores than ChatGPT ( p = 0.043) and demonstrated the highest overall reference quality. Qualitative analysis revealed critical pharmacological dosing errors, contextual blindness, temporal obsolescence, and a high frequency of fabricated citations. Conclusion: While current LLMs demonstrate good diagnostic pattern recognition in PGHN, reproducible and potentially life‐threatening failures in pharmacological reasoning and reference accuracy create a dangerous illusion of competence. These findings suggest that LLMs may support differential diagnosis brainstorming in PGHN but do not establish their safety in real‐world clinical scenarios.

  • Open Access

    Psychosocial outcomes in healthy siblings of children with celiac disease: A controlled cross-sectional study

    by Halenur Teke, Hilal Tuter Mavi, Selcuk Teke, Yasin Maruf Ergen, Birce Izgi Akçay, Mehmet Ayhan Congoloğlu, Necati Balamtekin

    Objective: The aim of this study was to compare health-related quality of life (QoL) and anxiety/depressive symptoms in healthy siblings of children with celiac disease (CD) with age- and gender-similar healthy siblings of children without chronic illness. Materials and Methods: This controlled cross-sectional study, conducted in a pediatric gastroenterology and child psychiatry setting at a tertiary-care hospital, enrolled healthy siblings aged 8–17 years into a CD-sibling group (n=70) and a control group (n=70). Sociodemographic data were collected using a standardized form, QoL was assessed using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales, and psychiatric symptoms were assessed using the Revised Child Anxiety and Depression Scale (RCADS). Between-group comparisons and Spearman rank correlations were used, and predictors of total anxiety and psychosocial QoL were examined using univariable and multivariable linear regression. Results: Sociodemographic and familial characteristics were largely comparable between groups. Compared with controls, the CD-sibling group had higher total anxiety scores (p=0.007), whereas depressive symptoms were similar between groups (p=0.758). Psychosocial and total QoL were lower in the CD-sibling group (both p<0.001), while physical QoL did not differ between groups (p=0.201). In multivariable models within the CD-sibling group, longer time since diagnosis and maternal psychiatric disorder independently predicted higher anxiety and poorer psychosocial QoL, whereas a greater number of siblings predicted lower anxiety and better psychosocial QoL. Conclusion: Healthy siblings of children with CD experience increased anxiety and reduced psychosocial/total QoL, underscoring the importance of family-centered monitoring that includes sibling well-being and maternal mental health.

  • Challenge of diagnosing celiac disease in pediatric type 1 diabetes mellitus: lessons from long-term serological surveillance

    by Selcuk Teke, Ceyda Tuna Kırsaclıoglu, Necati Emrecan Turk, Ahmet Kara, Zehra Aycan, Aydan Kansu, Arzu Ensari, Zarife Kuloglu

    1. Characterized by the targeted destruction of pancreatic beta cells, type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease that ultimately leads to permanent insulin deficiency [1–3]. C...

  • Open Access

    Bone mineral density in pediatric celiac disease: Clinical, biochemical, and serologic profiles—a retrospective cohort study

    by Selcuk Teke, Edibe Gozde Basaran

    Objective: The aim of this study was delineate the burden of low lumbar bone mineral density (BMD) in children with CD (celiac disease) and evaluate differences in BMD according to assessment timing and gluten-free diet (GFD) adherence, using concurrent tissue transglutaminase IgA (c-tTG-IgA), and describe accompanying anthropometric and biochemical profiles. Materials and Methods: This retrospective cohort included CD patients (n=123) aged 5–18 years who underwent dual-energy X-ray absorptiometry (DEXA) between January 1, 2022, and December 31, 2024. Age-adjusted and height-adjusted BMD z-scores (BMD-AAz and BMD-HAz) were calculated. Patients were grouped as diagnosis or follow-up (≥12 months), and follow-up was subdivided into GFD-non-adherent follow-up group (FU-NonAdh) and GFD-adherent follow-up group (FU-Adh). Results: Low BMD based on BMD-HAz (≤−1) was present in 37.4% (osteopenia 24.4%; osteoporosis 13.0%). Compared with diagnosis group, follow-up group had higher BMD-AAz and BMD-HAz (p=0.022 and p=0.011). BMD-HAz was higher in FU-Adh group than in diagnosis and FU-NonAdh group (p<0.001 and p=0.005), whereas FU-NonAdh group did not differ from diagnosis group. The low BMD group had a lower body mass index (BMI) z-score and shorter GFD duration (p<0.001 and p=0.010). Serum calcium levels were lower in the osteoporosis group than in the normal BMD group (p=0.003). Conclusion: Lumbar BMD impairment is frequent in pediatric CD, with the most evident improvement in the GFD-adherent follow-up group. In secondary analyses, lower BMI z-scores and shorter GFD duration were observed in children with low BMD, which may help inform risk stratification.

  • Open Access

    Thrombotic Risk and Hemostatic Profiles in Pediatric Inflammatory Bowel Disease: Association with Disease Activity

    by Yasin Maruf Ergen, Edibe Gözde Başaran, Selçuk Teke, Tuğba Çaviş, Necati Balamtekin

    Background/Aims: Inflammatory bowel disease (IBD) increases thromboembolic risk, but pediatric evidence remains limited. The current study evaluated the associations between coagulation markers, systemic inflammation, and disease activity in pediatric IBD and assessed the prevalence of silent thrombosis. Materials and Methods: A total of 46 pediatric patients with IBD were enrolled in this single-center cross-sectional study. All underwent Doppler ultrasonography of the lower extremities and the portal venous system. Hemostatic and inflammatory markers were evaluated in the laboratory and were analyzed in relation to disease activity. Results: One asymptomatic thrombus was detected in a patient with Crohn’s disease (CD). Factor VIII was significantly higher in ulcerative colitis (UC) compared to CD (median 109.5 vs. 74.3 IU/dL, P = .007). In UC, platelet count and D-dimer increased with increasing disease activity and extent. There was a significant relationship between platelet counts and the endoscopic extent (P = .008) and Mayo Score (P = .031). In CD, fibrinogen and factor VIII levels revealed a positive correlation with Pediatric Crohn’s Disease Activity Index scores (P = .012 and P = .040, respectively) but not with the Simple Endoscopic Score. Corticosteroid use was linked to higher factor VII (P = .017). Conclusion: Asymptomatic thrombosis rare in IBD, but inflammation and procoagulant activity were closely related, especially in UC. Platelet count, D-dimer, and factor VIII might serve as biomarkers for thrombotic risk and monitoring. Cite this article as: Ergen YM, Başaran EG, Teke S, .aviş T, Balamtekin N. Thrombotic risk and hemostatic profiles in pediatric inflammatory bowel disease: Association with disease activity. Turk J Gastroenterol. Published online March 24, 2026. doi: 10.5152/ tjg.2026.25541.

  • Diagnostic utility of shear wave elastography in pediatric celiac disease: Assessment of mesenteric and ileal stiffness

    by Yasin Maruf Ergen, Tuğba Çaviş, Selçuk Teke, Edibe Gözde Başaran, Birce İzGi Akçay, Necati Balamtekin

    Objective: To investigate the diagnostic utility of abdominal shear wave elastography (SWE) in pediatric celiac disease (CD) by assessing mesenteric and terminal ileal stiffness and its association with serologic activity, histologic severity, and gluten‐free diet (GFD) duration. Methods: In this prospective study, 84 children with CD and 80 matched healthy controls were evaluated. Mesenteric and terminal ileal stiffness values were measured using SWE. CD patients were stratified by GFD duration (short‐term: ≤6 months vs. long‐term: >6 months) and tissue transglutaminase immunoglobulin A (tTG‐IgA) levels. Diagnostic performance was determined using receiver operating characteristic (ROC) curves. Results: Mesenteric and ileal SWE values were significantly higher in CD patients than controls ( p < 0.001 for both). Mesenteric stiffness demonstrated an area under the ROC curve (AUC) of 0.81 with an optimal cut‐off of 9.03 kPa, while ileal stiffness showed an AUC of 0.83 with a cut‐off of 9.71 kPa. Subgroup analysis revealed no significant difference in baseline Marsh scores between the short‐term and long‐term GFD groups ( p = 0.305), despite a dramatic decline in tTG‐IgA levels in the long‐term group ( p < 0.001). Elevated stiffness persisted in both newly diagnosed and GFD‐treated patients compared with controls (all p < 0.001). No significant correlations were observed between SWE values and concurrent tTG‐IgA levels or Marsh subtypes (all p > 0.05). Conclusion: Increased mesenteric and ileal stiffness in children with CD likely reflect transmural involvement and structural remodeling beyond the mucosal injury. These findings demonstrate that SWE has good diagnostic utility and may serve as a valuable complementary noninvasive tool in the evaluation and clinical monitoring of pediatric CD.